{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T09:10:06Z","timestamp":1756804206503,"version":"3.44.0"},"reference-count":61,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15235","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T05:37:02Z","timestamp":1755581822000},"page":"1-14","source":"Crossref","is-referenced-by-count":0,"title":["Functional analysis of the effect of isoimperatorin on human acute monocytic leukemia at the transcriptome level"],"prefix":"10.3892","volume":"30","author":[{"given":"Runyang","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region 010050, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Oncology Hematology, Zibo 148 Hospital, Zibo, Shandong 255399, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ming","sequence":"additional","affiliation":[{"name":"Department of Oncology Hematology, Zibo 148 Hospital, Zibo, Shandong 255399, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juntao","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region 010050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"key20250902113647_b1-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41568-021-00355-z","article-title":"Leukaemia: A model metastatic disease","volume":"21","author":"Whiteley","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"key20250902113647_b2-ol-30-4-15235","first-page":"46","article-title":"Acute myeloid leukemia management and research in 2025","volume":"75","author":"Kantarjian","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"key20250902113647_b3-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.leukres.2007.06.019","article-title":"The morphological subcategories of acute monocytic leukemia (M5a and M5b) share similar immunophenotypic and cytogenetic features and clinical outcomes","volume":"32","author":"Villeneuve","year":"2008","journal-title":"Leuk Res"},{"key":"key20250902113647_b4-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S1470-2045(22)00637-4","article-title":"Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): Results from a population-based study","volume":"23","author":"Botta","year":"2022","journal-title":"Lancet Oncol"},{"key":"key20250902113647_b5-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1007\/s00277-023-05324-0","article-title":"Comparison of outcomes for patients with acute myeloid leukemia undergoing haploidentical stem cell transplantation in first and second complete remission","volume":"102","author":"Yu","year":"2023","journal-title":"Ann Hematol"},{"key":"key20250902113647_b6-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/ajh.27126","article-title":"Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age","volume":"99","author":"Saliba","year":"2024","journal-title":"Am J Hematol"},{"key":"key20250902113647_b7-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13046-023-02841-8","article-title":"Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment","volume":"42","author":"Peroni","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"key20250902113647_b8-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.trecan.2025.01.011","article-title":"Metabolism and therapeutic response in acute myeloid leukemia with IDH1\/2 mutations","volume":"11","author":"Gabellier","year":"2025","journal-title":"Trends Cancer"},{"key":"key20250902113647_b9-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40364-025-00738-6","article-title":"Unveiling the potential of CLL-1: A promising target for AML therapy","volume":"13","author":"Soleimani Samarkhazan","year":"2025","journal-title":"Biomark Res"},{"key":"key20250902113647_b10-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2021.12.029","article-title":"Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma","volume":"164","author":"Brivio","year":"2022","journal-title":"Eur J Cancer"},{"key":"key20250902113647_b11-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1182\/blood.2021015246","article-title":"Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML","volume":"141","author":"Roas","year":"2023","journal-title":"Blood"},{"key":"key20250902113647_b12-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1182\/blood.2024026232","article-title":"Menin inhibitors in the treatment of acute myeloid leukemia","volume":"145","author":"Huls","year":"2025","journal-title":"Blood"},{"key":"key20250902113647_b13-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/jamaoncol.2024.2662","article-title":"Contemporary management of acute myeloid leukemia: A review","volume":"10","author":"Venugopal","year":"2024","journal-title":"JAMA Oncol"},{"key":"key20250902113647_b14-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"116585","DOI":"10.1016\/j.taap.2023.116585","article-title":"The landscape of novel strategies for acute myeloid leukemia treatment: Therapeutic trends, challenges, and future directions","volume":"473","author":"Wu","year":"2023","journal-title":"Toxicol Appl Pharmacol"},{"key":"key20250902113647_b15-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"15325","DOI":"10.3390\/ijms242015325","article-title":"Hematologic Neoplasms associated with down syndrome: Cellular and molecular heterogeneity of the diseases","volume":"24","author":"Peroni","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20250902113647_b16-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1146\/annurev-pathmechdis-051222-013421","article-title":"Haploinsufficient transcription factors in myeloid neoplasms","volume":"19","author":"Martinez","year":"2024","journal-title":"Annu Rev Pathol"},{"key":"key20250902113647_b17-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1182\/blood.2022018092","article-title":"Metabolism in acute myeloid leukemia: Mechanistic insights and therapeutic targets","volume":"141","author":"Mishra","year":"2023","journal-title":"Blood"},{"key":"key20250902113647_b18-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"1258151","DOI":"10.3389\/fphar.2023.1258151","article-title":"Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia","volume":"14","author":"Smoljo","year":"2023","journal-title":"Front Pharmacol"},{"key":"key20250902113647_b19-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1021\/acs.jnatprod.9b00567","article-title":"Antiproliferative pterocarpans and coumestans from lespedeza bicolor","volume":"82","author":"Thuy","year":"2019","journal-title":"J Nat Prod"},{"key":"key20250902113647_b20-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"20220541","DOI":"10.1515\/biol-2022-0541","article-title":"Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1\/2 and NF-\u03baB pathways","volume":"18","author":"Fan","year":"2023","journal-title":"Open Life Sci"},{"key":"key20250902113647_b21-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.3390\/ijms25084248","article-title":"Apoptotic effect of isoimpertorin via inhibition of c-Myc and SIRT1 signaling axis","volume":"25","author":"Ko","year":"2024","journal-title":"Int J Mol Sci"},{"key":"key20250902113647_b22-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"110433","DOI":"10.1016\/j.cellsig.2022.110433","article-title":"Isoimperatorin down-regulates epithelial mesenchymal transition through modulating NF-\u03baB signaling and CXCR4 expression in colorectal and hepatocellular carcinoma cells","volume":"99","author":"Kim","year":"2022","journal-title":"Cell Signal"},{"key":"key20250902113647_b23-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20250902113647_b24-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40364-024-00649-y","article-title":"Global, regional, and national burden of acute myeloid leukemia, 1990\u20132021: A systematic analysis for the global burden of disease study 2021","volume":"12","author":"Zhou","year":"2024","journal-title":"Biomark Res"},{"key":"key20250902113647_b25-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"111004","DOI":"10.1016\/j.cellsig.2023.111004","article-title":"Mitocurcumin utilizes oxidative stress to upregulate JNK\/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia","volume":"114","author":"Gaur","year":"2024","journal-title":"Cell Signal"},{"key":"key20250902113647_b26-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"216969","DOI":"10.1016\/j.canlet.2024.216969","article-title":"The opportunities and challenges of using PD-1\/PD-L1 inhibitors for leukemia treatment","volume":"593","author":"Xu","year":"2024","journal-title":"Cancer Lett"},{"key":"key20250902113647_b27-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12943-024-02121-9","article-title":"Programmed death receptor (PD-)1\/PD-ligand (L)1 in urological cancers: The \u2018all-around warrior\u2019 in immunotherapy","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"key20250902113647_b28-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.3390\/cancers15225409","article-title":"Treatment of acute myeloid leukemia in older adults","volume":"15","author":"Alsouqi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"key20250902113647_b29-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000534897","article-title":"Non-immunotherapy approaches for Relapsed or Refractory AML: An update for 2024","volume":"147","author":"Buchrits","year":"2024","journal-title":"Acta Haematol"},{"key":"key20250902113647_b30-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12935-023-03142-y","article-title":"GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3-ITD acute myeloid leukemia","volume":"23","author":"Xiao","year":"2023","journal-title":"Cancer Cell Int"},{"key":"key20250902113647_b31-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/ph16050767","article-title":"Natural product-based screening for lead compounds targeting SARS CoV-2 Mpro","volume":"16","author":"Chen","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"key20250902113647_b32-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"129326","DOI":"10.1016\/j.bmcl.2023.129326","article-title":"Design, syntheses and biological evaluation of natural product aiphanol derivatives and analogues: Discovery of potent anticancer agents","volume":"90","author":"Yao","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"key20250902113647_b33-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"1103940","DOI":"10.3389\/fphar.2023.1103940","article-title":"Isoimperatorin therapeutic effect against aluminum induced neurotoxicity in albino mice","volume":"14","author":"Rajendran","year":"2023","journal-title":"Front Pharmacol"},{"key":"key20250902113647_b34-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1158\/0008-5472.CAN-23-2804","article-title":"BCL-xL targeting to induce apoptosis and to eliminate chemotherapy-induced senescent tumor cells: From navitoclax to platelet-sparing BCL-xL PROTACs","volume":"83","author":"Skwarska","year":"2023","journal-title":"Cancer Res"},{"key":"key20250902113647_b35-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"2138186","DOI":"10.1155\/2020\/2138186","article-title":"Isoimperatorin induces apoptosis of nasopharyngeal carcinoma cells via the MAPK\/ERK1\/2 signaling pathway","volume":"2020","author":"Liu","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"key20250902113647_b36-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/cells8111403","article-title":"Adhesion deregulation in acute myeloid leukaemia","volume":"8","author":"Gruszka","year":"2019","journal-title":"Cells"},{"key":"key20250902113647_b37-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1038\/s41467-023-41770-0","article-title":"Distinct and targetable role of calcium-sensing receptor in leukaemia","volume":"14","author":"Pereira","year":"2023","journal-title":"Nat Commun"},{"key":"key20250902113647_b38-ol-30-4-15235","first-page":"1244","article-title":"Quercetin induces autophagy-associated death in HL-60 cells through CaMKK\u03b2\/AMPK\/mTOR signal pathway","volume":"54","author":"Xiao","year":"2022","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"key20250902113647_b39-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/cells11030543","article-title":"Put in a \u2018Ca2+ll\u2019 to acute myeloid leukemia","volume":"11","author":"Lewuillon","year":"2022","journal-title":"Cells"},{"key":"key20250902113647_b40-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.1074\/jbc.M205528200","article-title":"Calcium induces cell survival and proliferation through the activation of the MAPK pathway in a human hormone-dependent leukemia cell line, TF-1","volume":"278","author":"Ap\u00e1ti","year":"2003","journal-title":"J Biol Chem"},{"key":"key20250902113647_b41-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.4049\/jimmunol.165.7.3647","article-title":"Bacterial lipopolysaccharide, TNF-alpha, and calcium ionophore under serum-free conditions promote rapid dendritic cell-like differentiation in CD14+ monocytes through distinct pathways that activate NK-kappa B","volume":"165","author":"Lyakh","year":"2000","journal-title":"J Immunol"},{"key":"key20250902113647_b42-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/sj.leu.2404248","article-title":"Bcl2 phosphorylation and active PKC alpha are associated with poor survival in AML","volume":"20","author":"Kurinna","year":"2006","journal-title":"Leukemia"},{"key":"key20250902113647_b43-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/978-3-030-34521-1_20","article-title":"Non-anticoagulant heparins as heparanase inhibitors","volume":"1221","author":"Cassinelli","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"key20250902113647_b44-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.2147\/JIR.S350109","article-title":"Microglia-mediated neuroinflammation: A potential target for the treatment of cardiovascular diseases","volume":"15","author":"Wang","year":"2022","journal-title":"J Inflamm Res"},{"key":"key20250902113647_b45-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.3390\/cells10113058","article-title":"Integrated N- and O-glycomics of acute myeloid leukemia (AML) cell lines","volume":"10","author":"Bl\u00f6chl","year":"2021","journal-title":"Cells"},{"key":"key20250902113647_b46-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jsbmb.2015.09.033","article-title":"Biological evaluation of new vitamin D2 analogues","volume":"164","author":"Corcoran","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key20250902113647_b47-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"102452","DOI":"10.1016\/j.redox.2022.102452","article-title":"Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS\/p38 MAPK\/DGAT1 pathway and inhibiting M2 macrophage polarization","volume":"56","author":"Liu","year":"2022","journal-title":"Redox Biol"},{"key":"key20250902113647_b48-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"100950","DOI":"10.1016\/j.blre.2022.100950","article-title":"Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia","volume":"55","author":"Ung","year":"2022","journal-title":"Blood Rev"},{"key":"key20250902113647_b49-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"key":"key20250902113647_b50-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"e1062208","DOI":"10.1080\/2162402X.2015.1062208","article-title":"Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome","volume":"5","author":"Kittang","year":"2016","journal-title":"Oncoimmunology"},{"key":"key20250902113647_b51-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"e12852","DOI":"10.1111\/sji.12852","article-title":"Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sj\u00f6gren's syndrome to facilitate their concerted migration","volume":"91","author":"Blokland","year":"2020","journal-title":"Scand J Immunol"},{"key":"key20250902113647_b52-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"4024887","DOI":"10.1155\/2023\/4024887","article-title":"Mesenchymal stem cell-derived exosomal miRNA-222-3p increases Th1\/Th2 ratio and promotes apoptosis of acute myeloid leukemia cells","volume":"2023","author":"Yuan","year":"2023","journal-title":"Anal Cell Pathol (Amst)"},{"key":"key20250902113647_b53-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/cbf.3511","article-title":"IRF2-INPP4B axis inhibits apoptosis of acute myeloid leukaemia cells via regulating T helper 1\/2 cell differentiation","volume":"38","author":"Zhang","year":"2020","journal-title":"Cell Biochem Funct"},{"key":"key20250902113647_b54-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.it.2008.01.005","article-title":"T-cell fate and function: PKC-theta and beyond","volume":"29","author":"Marsland","year":"2008","journal-title":"Trends Immunol"},{"key":"key20250902113647_b55-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s11845-020-02382-5","article-title":"The correlation between Jun N-terminal kinase pathway-associated phosphatase and Th1 cell or Th17 cell in sepsis and their potential roles in clinical sepsis management","volume":"190","author":"Yu","year":"2021","journal-title":"Ir J Med Sci"},{"key":"key20250902113647_b56-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3390\/cells11010139","article-title":"Insights into modern therapeutic approaches in pediatric acute leukemias","volume":"11","author":"Panuciak","year":"2022","journal-title":"Cells"},{"key":"key20250902113647_b57-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"e2407189","DOI":"10.1002\/adma.202407189","article-title":"Systemic multifunctional nanovaccines for potent personalized immunotherapy of acute myeloid leukemia","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv Mater"},{"key":"key20250902113647_b58-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12974-015-0414-5","article-title":"The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis","volume":"12","author":"Gharagozloo","year":"2015","journal-title":"J Neuroinflammation"},{"key":"key20250902113647_b59-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"28507","DOI":"10.1074\/jbc.M004323200","article-title":"Polyomavirus enhancer-binding protein 2\/core binding factor\/acute myeloid leukemia factors contribute to the cell type-specific activity of the CD11a integrin gene promoter","volume":"275","author":"Puig-Kr\u00f6ger","year":"2000","journal-title":"J Biol Chem"},{"key":"key20250902113647_b60-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.7150\/thno.84388","article-title":"HMGB1-mediated elevation of KLF7 facilitates hepatocellular carcinoma progression and metastasis through upregulating TLR4 and PTK2","volume":"13","author":"Feng","year":"2023","journal-title":"Theranostics"},{"key":"key20250902113647_b61-ol-30-4-15235","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12885-017-3827-y","article-title":"Protein kinase C \u03b1 enhances migration of breast cancer cells through FOXC2-mediated repression of p120-catenin","volume":"17","author":"Pham","year":"2017","journal-title":"BMC Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T08:36:51Z","timestamp":1756802211000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8,19]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15235","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"type":"print","value":"1792-1074"},{"type":"electronic","value":"1792-1082"}],"subject":[],"published":{"date-parts":[[2025,8,19]]}}}